BALTIMORE – Second quarter payments for respiratory drugs are up in most cases, with the exception of Budesonide (J7626), which decreased sharply, down nearly 73 cents per dose.
BALTIMORE – When it comes to nebulizer medication pricing, one quarter you’re up; another quarter you’re down.
BALTIMORE – Things are looking up for several respiratory medications in the latest average sales price (ASP) figures. For the fourth quarter 2013, budesonide (J7626) took the biggest leap, up 85 cents to $5.95 per dose.
BALTIMORE – Pricing for budesonide took a plunge in the latest average sales price (ASP) figures for respiratory medications released in March.
BALTIMORE – Brand-name Brovana took a hit in the latest average sales price (ASP) figures for nebulizer medications, but otherwise there were few major changes.
As of Oct. 1, provider Sam Jarczynski no longer planned to dispense budesonide.
© 2017 United Publications Inc. ALL RIGHTS RESERVED